Australia-based Mayne Pharma sells US generic prescription product portfolio for $90 M

Dr. Reddy's Laboratories SA, a wholly-owned subsidiary of Indian pharmaceutical company Dr. Reddy’s Laboratories, ...

February 28, 2023 | Tuesday | News
New funding bolsters medical and science research collaborations in Australia

Australia's University of Sydney medical and science researchers will be involved in two successful Cooperative Res...

February 27, 2023 | Monday | News
European Union approves first gene therapy for hemophilia B

Australian biotechnology leader CSL has announced that the European Commission has granted conditional marketing authori...

February 23, 2023 | Thursday | News
South Australian Government takes new initiatives to develop biomanufacturing sector

Biomanufacturing sector will be given a boost by the South Australian Government’s announcement of new initiatives...

February 22, 2023 | Wednesday | News
Funding injection of $8 M for Strep A vaccine research in Australia

Australia's University of Queensland (UQ)-led research effort to develop an mRNA vaccine against Group A Streptococcus (...

February 20, 2023 | Monday | News
Australia's Inventia partners with Merck to develop 3D models for neuro disease drug discovery

Australia-based startup Inventia Life Science has partnered with American pharmaceutical firm Merck using Inventia'...

February 17, 2023 | Friday | News
Australia develops first biotech ESG guidance

A group of dedicated AusBiotech leaders have banded together to develop an Australian biotech first, a sector-specific &...

February 16, 2023 | Thursday | News
Groundbreaking trial underway for treatment of advanced Retinitis Pigmentosa in Australia

In collaboration with US-based Kiora Pharmaceuticals, Inc. and The Royal Adelaide Hospital, leading Australian Contract ...

February 15, 2023 | Wednesday | News
Australia discovers receptor that blocks COVID-19 infection

Australia's University of Sydney scientists have discovered a protein in the lung that blocks SARS-CoV-2 infection and f...

February 14, 2023 | Tuesday | News
Ph I trial of first needle-free influenza vaccine begins in Australia

Australian biotech firm Vaxxas has announced the initiation of a Phase I clinical trial with the first inactivated ...

February 13, 2023 | Monday | News
Australian firm AcuraBio partners with Cytiva to expand cGMP plasmid DNA CDMO services

AcuraBio, a leading Australian biopharmaceutical contract development and manufacturing organisation (CDMO), will provid...

February 10, 2023 | Friday | News
Griffith University in Australia partners with health tech accelerator programme

Griffith University in Australia has committed to a three-year partnership with a leading health technology accelerator ...

February 9, 2023 | Thursday | News
Australia uses machine learning to advance Alzheimer's research

Scientists from Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australia’s national sc...

February 8, 2023 | Wednesday | News
Australia moves from two doses to one of HPV vaccine for routine immunisation

The Australian government has announced to shift from two doses to a single dose of the Gardasil9 human papillomavirus (...

February 6, 2023 | Monday | News
"Australia is poised to establish itself as a global life sciences hub"

How would you describe the assay and bioreagents market in Australia and New Zealand? What impact does the Assay Matrix ...

February 6, 2023 | Monday | Opinion
Agilex Biolabs announces new CEO

Agilex Biolabs, Australia’s largest and most technologically advanced regulated bioanalytical and tox...

February 3, 2023 | Friday | News
Genetic Technologies, Qiagen to establish Centre of Excellence facility in Australia

Australian firm Genetic Technologies Limited (GTG), a global leader in guideline-driven genomics-based tests in health, ...

February 3, 2023 | Friday | News
Australia invests $3.9 M to prevent and support workers with incurable dust disease

The government is taking action to reduce the rates of occupational respiratory disease in Australia ...

February 2, 2023 | Thursday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls